Publikationen, an denen er mitarbeitet José Antonio Páramo Fernández (39)

2023

  1. Immunothrombosis: Molecular Aspects and New Therapeutic Perspectives

    Journal of Clinical Medicine, Vol. 12, Núm. 4

2022

  1. CM-352 Efficacy in a Mouse Model of Anticoagulant-Associated Intracranial Hemorrhage

    Thrombosis and Haemostasis, Vol. 122, Núm. 8, pp. 1314-1325

  2. Impact of the mutation profile on thrombotic risk in cancer patients

    Revista Clinica Espanola, Vol. 222, Núm. 2, pp. 93-99

2021

  1. Inside the Thrombus: Association of Hemostatic Parameters With Outcomes in Large Vessel Stroke Patients

    Frontiers in Neurology, Vol. 12

2019

  1. Analysis of monocitary subpopulations in relation to cardiovascular risk factors

    Clinica e Investigacion en Arteriosclerosis, Vol. 31, Núm. 4, pp. 152-159

  2. Análisis de subpoblaciones monocitarias en relación con los factores de riesgo cardiovascular

    Clínica e investigación en arteriosclerosis, Vol. 31, Núm. 4, pp. 152-159

  3. Differences in Venous Thromboembolism Prevention and Outcome between Hospitalized Patients with Solid and Hematologic Malignancies

    TH Open

  4. Improvement of appropriate pharmacological prophylaxis in hospitalised cancer patients with a multiscreen e-alert system: a single-centre experience

    Clinical and Translational Oncology, Vol. 21, Núm. 6, pp. 805-809

  5. New mechanisms in vein thrombosis: Immunothrombosis

    Medicina Clinica, Vol. 153, Núm. 2, pp. 78-81

  6. Surgical thromboprophylaxis in daily urologic surgery: Beyond bridge therapy

    Actas Urologicas Espanolas, Vol. 43, Núm. 9, pp. 455-466

2018

  1. Insights into venous thromboembolism prevention in hospitalized cancer patients: Lessons from a prospective study

    PLoS ONE, Vol. 13, Núm. 8

2016

  1. Identification of new markers of recurrence in patients with unprovoked deep vein thrombosis by gene expression profiling: the retro study

    European Journal of Haematology, Vol. 97, Núm. 2, pp. 128-136

  2. La aplicación de un protocolo de gestión para la hemorragia masiva reduce la mortalidad en pacientes con hemorragia no traumática: Resultados de la auditoría de un centro

    Medicina Intensiva, Vol. 40, Núm. 9, pp. 550-559

2015

  1. Factors influencing the use of thromboprophylaxis in cancer outpatients in clinical practice: A prospective study

    Thrombosis Research, Vol. 136, Núm. 6, pp. 1145-1148

  2. Short-term heparin re-exposure during heart transplantation in patients with ventricular assist devices and acute heparin-induced thrombocytopenia

    Revista Espanola de Cardiologia

2014

  1. Seguridad y eficacia de un concentrado de complejo protrombínico en pacientes con coagulopatía y hemorragia

    Anales del sistema sanitario de Navarra, Vol. 37, Núm. 3, pp. 363-369

2013

  1. High incidence of venous thromboembolism despite electronic alerts for thromboprophylaxis in hospitalised cancer patients

    Thrombosis and Haemostasis, Vol. 110, Núm. 1, pp. 184-190

  2. Screening for occult malignancy with FDG-PET/CT in patients with unprovoked venous thromboembolism

    International Journal of Cancer, Vol. 133, Núm. 9, pp. 2157-2164

2012

  1. Adipose stromal vascular fraction improves cardiac function in chronic myocardial infarction through differentiation and paracrine activity

    Cell Transplantation, Vol. 21, Núm. 5, pp. 1023-1037

  2. Trombofilia y trombosis

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 11, Núm. 22, pp. 1345-1352